You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 11, March 17, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •PET/ SPECT Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Whole-Body Imaging for Cancer Staging

Since this article does not have an abstract, we have provided the first 124 words of the full text and any section headings.

To the Editor: Dr Antoch and colleagues1 reported that combined whole-body positron emission tomography and computed tomography (PET/CT) had greater diagnostic accuracy for cancer staging than did whole-body magnetic resonance imaging (MRI). I believe, however, that the authors' use of the term whole body is misleading, as their axial scanning range for both PET/CT and MRI did not appear to examine the brain, skull, or lower extremities. Lung cancer, for instance, commonly metastasizes to the brain. Furthermore, contrast-enhanced MRI has been reported to have higher sensitivity and specificity for brain metastases than PET.2 Although true whole-body PET requires additional time for image acquisition, it may provide a more accurate staging.

Financial Disclosure: Dr Osman has received honoraria from Petnet Pharmaceuticals and Shared Medical Services.

Medhat M. Osman , MD, ScM, PhD
Department of Internal Medicine
Saint Louis University
Saint Louis, Mo

1. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199-3206. FREE FULL TEXT
2. Rohern EM, Provenzale JM, Barboriak DP, et al. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology. 2003;226:181-187. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291:1320.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.